DKF Med Care
June 30, 2016
Participate up to August 29, 2016 by completing the online consultation questionnaire.
October 15 and 16, 2016
February 24, 2016
Federal Court judge rules medical cannabis law unconstitutional
March 31, 2014
Health CanadaMedical Marihuana Purposes Regulations (MMPR) replaces
Health Canada Medical Marihuana Access Regulations (MMAR) program.
What we recommend now the old Health Canada MMAR program has changed to the MMPR program:
Offering our prescription writing services to all qualified patients at ZERO COST. Doctor Mason, the Alberta College of physicians as well as health Canada do however require that a 'diagnosis confirmation' be signed by a general practice doctor prior to specialist consult. That form can be found here: naturalhealthservices.ca/forms
Calgary doctor taking new patients and signing MMPR form (required for medical cannabis).
March 31, 2014
HEALTH CANADA MMAR LICENCE STATEMENT UPDATE:
For immediate release
As a result of ongoing litigation and uncertainty arising from court decisions, Health Canada will treat the following Authorizations to Possess, Personal-Use Production Licences, and Designated-Person Production Licences as extending beyond March 31, 2014 until a decision in Allard is rendered. As per the Federal Court interim injunction, the following criteria must be met:
•Individuals must have held a valid Authorizations to Possess under the MMAR on March 21, 2014.
•Individuals must have held a valid Personal-Use Production Licence or Designated-Person Production Licence under the MMAR on, or after, September 30, 2013, where there is also an associated valid ATP as of March 21, 2014.
July 8, 2015
Health Canada Statement
Statement on Supreme Court of Canada Decision in R. v. Smith
THC limited to only 3%! CBD, CBN and other compounds no limits!
Sativex – a liquid extract of marijuana plants used in the treatment of certain symptoms associated with multiple sclerosis and certain kinds of pain; and
Cesamet – a capsule containing a synthetic version of THC, used in the management of nausea and vomiting associated with cancer chemotherapy.
Section 56 Exemptions: